James H Cavanaugh is Director of LEAP THERAPEUTICS, INC.. Currently has a direct ownership of 213 shares of LPTX, which is worth approximately $619. The most recent transaction as insider was on Nov 13, 2024, when has been sold 213 shares (Common Stock) at a price of $2.82 per share, resulting in proceeds of $600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 213
n/a 3M change
n/a 12M change
Total Value Held $619

JAMES H CAVANAUGH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 13 2024
BUY
Exercise of in-the-money or at-the-money derivatives securities
$600 $2.82 p/Share
213 Added 50.0%
213 Common Stock
JHC

James H Cavanaugh

Director
Cambridge, MA

Track Institutional and Insider Activities on LPTX

Follow LEAP THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LPTX shares.

Notify only if

Insider Trading

Get notified when an Leap Therapeutics, Inc. insider buys or sells LPTX shares.

Notify only if

News

Receive news related to LEAP THERAPEUTICS, INC.

Track Activities on LPTX